Of 113 pancreatic
ductal adenocarcinoma samples studied, 86 contained gemcitabine - inactivating bacteria.
Not exact matches
To better understand the formation of metastases in pancreatic cancer, Christine Iacobuzio - Donahue, M.D., Ph.D., professor of pathology at Memorial Sloan Kettering Cancer Center, collected tumor
samples from eight patients with the most common form of pancreatic cancer (pancreatic
ductal adenocarcinoma) immediately after their deaths.
Bottom Line: Bacterial load was significantly higher in pancreatic tumor
samples from patients with pancreatic
ductal adenocarcinoma compared with pancreatic tissue from normal individuals, and in studies using mice, eliminating certain «bad» bacteria slowed the growth of pancreatic cancer, reversed immune suppression, and upregulated the immune checkpoint protein PD1.